GGrantIndex
Sort

78,016 grants matching breast cancer

Identification of small molecule modulators of mitochondrial creatine kinase 1

$520,361
Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA

NOVEL MECHANISMS OF PARP INHIBITOR RESISTANCE IN BRCA1-DEFICIENT BREAST CANCERS

$520,353
The General Hospital Corporation · · FY2013 · Department of the Army

INTERACTIVE DECISION AID FOR BRCA 1/2 MUTATION CARRIERS

$520,346
Georgetown University · R01 · FY2000 · CA

Genomic and functional approaches to characterize Chr1q gains in cancer

$520,332
Jason Sheltzer · Yale University · R01 · FY2025 · CA

Measurement Errors in Cancer Epidemiology

$520,304
Donna L Spiegelman · Harvard School Of Public Health · R01 · FY2011 · CA

Glycosylation Mutants of Mice and Animal Cells

$520,266
Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2009 · CA

Administrative Core

$520,261
Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2016 · CA

Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort

$520,260
Mia Hashibe · University Of Utah · R01 · FY2020 · CA

GENOMICS OF HUMAN CANCER

$520,204
Cold Spring Harbor Laboratory · R01 · FY2002 · CA

Blood-to-CNS Drug Uptake in Pain

$520,101
Thomas Paul Davis · University Of Arizona · R01 · FY2009 · DA

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$520,078
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Breast CancerTherapeutic Subtype Therapeutic Responses: Eval. of Chemo. and Bio.

$520,046
Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2008 · CA

BRCA1 and BRCA2 missense mutations and breast cancer risk

$520,019
Fergus Joseph Couch · Mayo Clinic Rochester · U01 · FY2014 · CA

Kansas City Clinical Oncology Program CCOP

$520,000
Rakesh Gaur · Nci Community Oncology Research Program · U10 · FY2009 · CA

Magnetic Particle Microscopy of Living Organisms

$519,994
Pallavi Dhagat · Oregon State University · · FY2013 · ENG

Ceramide, Membrane Glycolipids and Glycoprotein Expression

$519,933
Myles C Cabot · Saint John'S Cancer Institute · R01 · FY2010 · GM

South Carolina Cancer Disparities Research Center (SC CaDRe)

$519,832
Judith Salley · South Carolina State University · U54 · FY2022 · CA

Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system

$519,825
Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2024 · CA

Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent

$519,807
Seth J Field · Case Western Reserve University · R01 · FY2024 · CA

Statistical Methods for Genetic Epidemiology

$519,796
Stanford University · R01 · FY2003 · CA

Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis

$519,766
Dorothy A Sipkins · Duke University · R01 · FY2023 · CA

Academic-Industrial Partnership for Translation of Acoustic Angiography

$519,752
Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA

Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers

$519,730
Paul Joseph Goodfellow · Ohio State University · R01 · FY2019 · CA

Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer

$519,704
Noriyuki Kasahara · University Of California, San Francisco · R01 · FY2022 · CA

Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity

$519,681
Brian C Jensen · Univ Of North Carolina Chapel Hill · R01 · FY2025 · HL